Correlation Between Novo Nordisk and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and Seres Therapeutics, you can compare the effects of market volatilities on Novo Nordisk and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and Seres Therapeutics.
Diversification Opportunities for Novo Nordisk and Seres Therapeutics
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Novo and Seres is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Novo Nordisk and Seres Therapeutics
Assuming the 90 days trading horizon Novo Nordisk is expected to generate 6.71 times less return on investment than Seres Therapeutics. But when comparing it to its historical volatility, Novo Nordisk AS is 5.08 times less risky than Seres Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 61.00 in Seres Therapeutics on September 13, 2024 and sell it today you would earn a total of 23.00 from holding Seres Therapeutics or generate 37.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. Seres Therapeutics
Performance |
| Timeline |
| Novo Nordisk AS |
| Seres Therapeutics |
Novo Nordisk and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and Seres Therapeutics
The main advantage of trading using opposite Novo Nordisk and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Novo Nordisk vs. CAL MAINE FOODS | Novo Nordisk vs. Astral Foods Limited | Novo Nordisk vs. Tyson Foods | Novo Nordisk vs. THAI BEVERAGE |
| Seres Therapeutics vs. Perseus Mining Limited | Seres Therapeutics vs. SOUTHWEST AIRLINES | Seres Therapeutics vs. DISTRICT METALS | Seres Therapeutics vs. CHINA TONTINE WINES |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |